These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8194022)

  • 21. Circadian infusion of floxuridine in patients with metastatic renal cell carcinoma.
    Dexeus FH; Logothetis CJ; Sella A; Amato R; Kilbourn R; Ogden S; Striegel A; Kwan J; Newman RA
    J Urol; 1991 Sep; 146(3):709-13. PubMed ID: 1831513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of five-day continuous infusion of vinblastine in patients with metastatic renal-cell carcinoma.
    Crivellari D; Tumolo S; Frustaci S; Galligioni E; Figoli F; Lo Re G; Veronesi A; Monfardini S
    Am J Clin Oncol; 1987 Jun; 10(3):231-3. PubMed ID: 3591744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma.
    Bates SE; Bakke S; Kang M; Robey RW; Zhai S; Thambi P; Chen CC; Patil S; Smith T; Steinberg SM; Merino M; Goldspiel B; Meadows B; Stein WD; Choyke P; Balis F; Figg WD; Fojo T
    Clin Cancer Res; 2004 Jul; 10(14):4724-33. PubMed ID: 15269145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine.
    Braybrooke JP; Vallis KA; Houlbrook S; Rockett H; Ellmén J; Anttila M; Ganesan TS; Harris AL; Talbot DC
    Cancer Chemother Pharmacol; 2000; 46(1):27-34. PubMed ID: 10912574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Impact of immunochemotherapy on survival of patients with metastatic renal cell carcinoma. A retrospective study comparing interferon-alpha-2a/vinblastine versus interferon-alpha-2a/interleukin-2/5-fluorouracil].
    May M; Helke C; Bock M; Hoschke B
    Urologe A; 2004 Sep; 43(9):1111-9. PubMed ID: 15232686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxic chemotherapy for metastatic renal cell carcinoma.
    Stadler WM
    Urologe A; 2004 Sep; 43 Suppl 3():S145-6. PubMed ID: 15164180
    [No Abstract]   [Full Text] [Related]  

  • 27. Limited efficacy of interferon-alpha and vinblastine as second line biochemotherapy regimen in patients with progressive metastatic renal cell carcinoma.
    Lopez Hanninen E; Fenner M; Kirchner H; Deckert M; Duensing S; Menzel T; Poliwoda H; Atzpodien J
    Cancer Biother; 1993; 8(4):301-6. PubMed ID: 7804371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vinorelbine and infusional 5-fluorouracil in anthracycline and taxane pre-treated metastatic breast cancer.
    Stuart NS; McIllmurray MB; Bishop JL; Johnston SR; Price CG; O'Reilly SM; Joffe JK; Neave F; Whipp EC
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):152-6. PubMed ID: 18083354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
    Kemeny N; Seiter K; Conti JA; Cohen A; Bertino JR; Sigurdson ER; Botet J; Chapman D; Mazumdar M; Budd AJ
    Cancer; 1994 Feb; 73(4):1134-42. PubMed ID: 8313315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant alpha-interferon and vinblastine in metastatic renal cell carcinoma: efficacy of low doses.
    Cetto GL; Franceschi T; Turrina G; Chiarion-Sileni V; Capelli MC; Bellini A; Paccagnella A; Bassetto MA; Molino AM; de Sandre G
    Semin Surg Oncol; 1988; 4(3):184-90. PubMed ID: 3055162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circadian-based infusional FUDR therapy.
    Lanning RM; von Roemeling R; Hrushesky WJ
    Oncol Nurs Forum; 1990; 17(1):49-56. PubMed ID: 2137216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of recombinant interferon alpha-2a and vinblastine in advanced renal cell cancer.
    Bergerat JP; Herbrecht R; Dufour P; Jacqmin D; Bollack C; Prevot G; Bailly G; de Garis S; Juraschek F; Oberling F
    Cancer; 1988 Dec; 62(11):2320-4. PubMed ID: 3141036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronomodulated 5-day infusion of floxuridine and L-folinic acid in patients with advanced malignancies: a feasibility and tolerability study.
    Garufi C; Lévi F; Giunta S; Aschelter A; Pace R; Nisticò C; Terzoli E
    J Infus Chemother; 1995; 5(3 Suppl 1):134-7. PubMed ID: 8528973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study.
    Dutcher JP; Logan T; Gordon M; Sosman J; Weiss G; Margolin K; Plasse T; Mier J; Lotze M; Clark J; Atkins M
    Clin Cancer Res; 2000 Sep; 6(9):3442-50. PubMed ID: 10999727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer.
    Subramanyan S; Abeloff MD; Bond SE; Davidson NE; Fetting JH; Gordon GB; Kennedy MJ
    Cancer Chemother Pharmacol; 1999; 43(6):497-502. PubMed ID: 10321510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer.
    Toussaint C; Izzo J; Spielmann M; Merle S; May-Levin F; Armand JP; Lacombe D; Tursz T; Sunderland M; Chabot GG
    J Clin Oncol; 1994 Oct; 12(10):2102-12. PubMed ID: 7931480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous non chronomodulated infusion of floxuridine in metastatic renal cell carcinoma (MRCC): report of 17 cases.
    Baiocchi C; Landonio G; Cacioppo C; Calgaro M; Cattaneo D; Ferrari M; Majno M
    Tumori; 1996; 82(3):225-7. PubMed ID: 8693598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-2 chronotherapy for metastatic renal cell carcinoma: Results of a phase I-II study.
    Re GL; Santeufemia DA; Re FL; Bortolus R; Doretto P; Marus W; Buttazzi L; Lenardon O; Falda A; Piazza R; Sulfaro S
    Cytokine; 2020 Apr; 128():154984. PubMed ID: 31972343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study.
    Delva R; Pienkowski T; Tubiana N; Vanhoefer U; Longerey B; Douville I
    Cancer Chemother Pharmacol; 2007 May; 59(6):703-9. PubMed ID: 17021821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma.
    Einhorn LH; Roth BJ; Ansari R; Dreicer R; Gonin R; Loehrer PJ
    J Clin Oncol; 1994 Nov; 12(11):2271-6. PubMed ID: 7525884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.